Compounds > levonorgestrel
Page last updated: 2024-08-21

levonorgestrel and asoprisnil

levonorgestrel has been researched along with asoprisnil in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Manyonda, I; Talaulikar, VS1
Bastianelli, C; Benagiano, G; Brosens, I; Farris, M1
Abraham, T; Arian, SE; Bartels, CB; Cayton, KC; Chuong, FS; Holthouser, K; Segars, JH1
Centini, G; Kashani, BN; Morelli, SS; Petraglia, F; Weiss, G1

Reviews

4 review(s) available for levonorgestrel and asoprisnil

ArticleYear
Progesterone and progesterone receptor modulators in the management of symptomatic uterine fibroids.
    European journal of obstetrics, gynecology, and reproductive biology, 2012, Volume: 165, Issue:2

    Topics: Endometrium; Estrenes; Female; Hormone Antagonists; Humans; Hyperplasia; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Mifepristone; Norpregnadienes; Oximes; Receptors, Progesterone

2012
Selective progesterone receptor modulators: an update.
    Expert opinion on pharmacotherapy, 2014, Volume: 15, Issue:10

    Topics: Adenomyosis; Animals; Clinical Trials as Topic; Contraception, Postcoital; Contraceptive Agents, Female; Contraceptives, Postcoital; Endometriosis; Estrenes; Female; Hormone Antagonists; Humans; Leiomyoma; Levonorgestrel; Mifepristone; Norpregnadienes; Oximes; Receptors, Progesterone; Uterine Neoplasms

2014
An Evidence-based Approach to the Medical Management of Fibroids: A Systematic Review.
    Clinical obstetrics and gynecology, 2016, Volume: 59, Issue:1

    Topics: Androgens; Aromatase Inhibitors; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Curcumin; Delayed-Action Preparations; Drugs, Chinese Herbal; Estradiol; Estrenes; Estrogen Receptor Antagonists; Evidence-Based Medicine; Female; Fulvestrant; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Medroxyprogesterone Acetate; Mifepristone; Neoadjuvant Therapy; Norpregnadienes; Oximes; Plant Extracts; Receptors, Progesterone; Selective Estrogen Receptor Modulators; Tea; Uterine Myomectomy; Uterine Neoplasms; Vitamin D; Vitamins

2016
Role of Medical Management for Uterine Leiomyomas.
    Best practice & research. Clinical obstetrics & gynaecology, 2016, Volume: 34

    Topics: Antifibrinolytic Agents; Aromatase Inhibitors; Cabergoline; Cholecalciferol; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Danazol; Dopamine Agonists; Ergolines; Estrenes; Estrogen Antagonists; Female; Gestrinone; Gonadotropin-Releasing Hormone; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Mifepristone; Norpregnadienes; Oximes; Patient Care Planning; Selective Estrogen Receptor Modulators; Somatostatin; Tranexamic Acid; Uterine Neoplasms; Vitamins

2016